Steven Barger
Concepts (344)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 13 | 2024 | 317 | 3.430 |
Why?
| Glutamic Acid | 12 | 2023 | 108 | 2.620 |
Why?
| Microglia | 13 | 2023 | 140 | 2.480 |
Why?
| Amyloid beta-Peptides | 5 | 2023 | 65 | 2.290 |
Why?
| Brain | 17 | 2022 | 1328 | 2.260 |
Why?
| Neurons | 17 | 2022 | 460 | 2.240 |
Why?
| Gene Expression Regulation | 10 | 2016 | 979 | 1.890 |
Why?
| Amyloid beta-Protein Precursor | 8 | 2018 | 23 | 1.790 |
Why?
| NF-kappa B | 7 | 2016 | 315 | 1.700 |
Why?
| Racemases and Epimerases | 8 | 2012 | 15 | 1.500 |
Why?
| Apolipoproteins E | 5 | 2023 | 56 | 1.390 |
Why?
| Animals | 47 | 2024 | 13246 | 1.160 |
Why?
| Serine | 9 | 2022 | 37 | 1.050 |
Why?
| Astrocytes | 4 | 2020 | 146 | 0.990 |
Why?
| Cells, Cultured | 20 | 2016 | 1581 | 0.970 |
Why?
| Mice, Transgenic | 9 | 2023 | 550 | 0.920 |
Why?
| Insulin | 3 | 2020 | 456 | 0.830 |
Why?
| Peptide Fragments | 3 | 2020 | 213 | 0.810 |
Why?
| Glucose Transporter Type 1 | 1 | 2020 | 17 | 0.740 |
Why?
| Rats | 18 | 2016 | 3299 | 0.720 |
Why?
| Sp1 Transcription Factor | 4 | 2009 | 21 | 0.680 |
Why?
| Transcription Factor AP-1 | 2 | 2012 | 63 | 0.650 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2018 | 15 | 0.640 |
Why?
| Somatomedins | 1 | 2018 | 32 | 0.640 |
Why?
| Blood Glucose | 2 | 2020 | 435 | 0.620 |
Why?
| Rats, Sprague-Dawley | 13 | 2019 | 1586 | 0.620 |
Why?
| Membrane Proteins | 4 | 2018 | 353 | 0.610 |
Why?
| Transcription, Genetic | 3 | 2009 | 369 | 0.600 |
Why?
| Gene Expression | 4 | 2020 | 609 | 0.600 |
Why?
| Central Nervous System | 2 | 2016 | 85 | 0.570 |
Why?
| Neurochemistry | 1 | 2016 | 2 | 0.570 |
Why?
| Presenilin-1 | 1 | 2016 | 11 | 0.560 |
Why?
| LDL-Receptor Related Proteins | 1 | 2016 | 11 | 0.560 |
Why?
| Nerve Tissue Proteins | 3 | 2023 | 193 | 0.560 |
Why?
| Diet, High-Fat | 2 | 2018 | 220 | 0.560 |
Why?
| Interleukin-1beta | 2 | 2019 | 75 | 0.550 |
Why?
| Receptors, N-Methyl-D-Aspartate | 4 | 2022 | 127 | 0.540 |
Why?
| Obesity | 3 | 2020 | 1108 | 0.540 |
Why?
| Mice | 20 | 2024 | 5759 | 0.540 |
Why?
| Genetic Therapy | 1 | 2016 | 114 | 0.520 |
Why?
| Neuroglia | 2 | 2012 | 43 | 0.510 |
Why?
| Neuroprotective Agents | 3 | 2007 | 103 | 0.500 |
Why?
| Animals, Newborn | 8 | 2014 | 368 | 0.490 |
Why?
| Neurodegenerative Diseases | 2 | 2007 | 78 | 0.490 |
Why?
| Inflammation | 4 | 2011 | 604 | 0.480 |
Why?
| DNA Methylation | 1 | 2018 | 550 | 0.450 |
Why?
| Frontotemporal Dementia | 1 | 2013 | 3 | 0.450 |
Why?
| Superoxide Dismutase | 3 | 2012 | 114 | 0.450 |
Why?
| Humans | 31 | 2023 | 50208 | 0.450 |
Why?
| Mutation | 3 | 2016 | 1294 | 0.450 |
Why?
| Promoter Regions, Genetic | 3 | 2012 | 475 | 0.440 |
Why?
| Epigenesis, Genetic | 1 | 2016 | 378 | 0.440 |
Why?
| Apolipoprotein E4 | 3 | 2024 | 19 | 0.430 |
Why?
| Presynaptic Terminals | 1 | 2012 | 15 | 0.420 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2012 | 14 | 0.420 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2015 | 20 | 0.420 |
Why?
| Cytokines | 3 | 2017 | 613 | 0.420 |
Why?
| Interleukin-1alpha | 1 | 2012 | 11 | 0.410 |
Why?
| Oxidation-Reduction | 3 | 2011 | 320 | 0.410 |
Why?
| Reactive Nitrogen Species | 1 | 2012 | 22 | 0.410 |
Why?
| Cysteine | 1 | 2011 | 50 | 0.390 |
Why?
| Signal Transduction | 7 | 2023 | 1622 | 0.390 |
Why?
| Polymorphism, Genetic | 1 | 2012 | 181 | 0.390 |
Why?
| Sp4 Transcription Factor | 2 | 2009 | 3 | 0.380 |
Why?
| Neuronal Plasticity | 2 | 2016 | 56 | 0.370 |
Why?
| Dose-Response Relationship, Drug | 7 | 2015 | 1378 | 0.370 |
Why?
| Reactive Oxygen Species | 2 | 2013 | 408 | 0.370 |
Why?
| Hippocampus | 3 | 2018 | 228 | 0.370 |
Why?
| RNA, Small Interfering | 4 | 2016 | 215 | 0.360 |
Why?
| Extracellular Matrix Proteins | 2 | 2023 | 69 | 0.350 |
Why?
| Serine Endopeptidases | 2 | 2023 | 52 | 0.350 |
Why?
| Aging | 3 | 2022 | 688 | 0.350 |
Why?
| RNA, Messenger | 9 | 2018 | 1108 | 0.330 |
Why?
| Drug Interactions | 4 | 2012 | 208 | 0.320 |
Why?
| Lipopolysaccharides | 5 | 2012 | 194 | 0.320 |
Why?
| Plaque, Amyloid | 1 | 2008 | 14 | 0.320 |
Why?
| Schwann Cells | 2 | 2005 | 13 | 0.310 |
Why?
| Transcription Factors | 2 | 2016 | 564 | 0.300 |
Why?
| Interleukin-1 | 2 | 2005 | 104 | 0.300 |
Why?
| Cystine | 2 | 2023 | 11 | 0.290 |
Why?
| Male | 13 | 2023 | 25399 | 0.290 |
Why?
| Sp3 Transcription Factor | 1 | 2007 | 5 | 0.290 |
Why?
| Receptors, Glutamate | 1 | 2007 | 10 | 0.290 |
Why?
| Lithium Chloride | 1 | 2007 | 6 | 0.290 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2007 | 20 | 0.290 |
Why?
| Calpain | 1 | 2007 | 25 | 0.290 |
Why?
| Lipid Peroxidation | 1 | 2007 | 100 | 0.280 |
Why?
| Embryo, Mammalian | 4 | 2016 | 66 | 0.280 |
Why?
| Neurobiology | 1 | 2006 | 4 | 0.270 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 72 | 0.270 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2006 | 136 | 0.270 |
Why?
| Nerve Growth Factors | 2 | 2006 | 27 | 0.260 |
Why?
| Electrophoretic Mobility Shift Assay | 4 | 2017 | 73 | 0.260 |
Why?
| Apolipoprotein E3 | 2 | 2023 | 8 | 0.260 |
Why?
| Protein Binding | 5 | 2017 | 665 | 0.260 |
Why?
| Kynurenic Acid | 1 | 2005 | 5 | 0.250 |
Why?
| Amyloid Precursor Protein Secretases | 2 | 2016 | 11 | 0.250 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2005 | 96 | 0.250 |
Why?
| Amino Acid Isomerases | 1 | 2004 | 2 | 0.250 |
Why?
| Intellectual Property | 1 | 2004 | 5 | 0.250 |
Why?
| S100 Proteins | 1 | 2005 | 34 | 0.250 |
Why?
| Cognition | 2 | 2023 | 335 | 0.240 |
Why?
| Research Support as Topic | 1 | 2004 | 46 | 0.240 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 595 | 0.240 |
Why?
| Genotype | 2 | 2023 | 534 | 0.230 |
Why?
| Antiporters | 1 | 2023 | 19 | 0.230 |
Why?
| Blotting, Western | 4 | 2013 | 601 | 0.220 |
Why?
| Cerebral Cortex | 5 | 2013 | 200 | 0.220 |
Why?
| tau Proteins | 3 | 2016 | 26 | 0.220 |
Why?
| Transcription Factor RelA | 2 | 2016 | 30 | 0.220 |
Why?
| Female | 10 | 2023 | 26635 | 0.210 |
Why?
| Cooperative Behavior | 1 | 2004 | 227 | 0.210 |
Why?
| Enzyme Inhibitors | 4 | 2012 | 386 | 0.210 |
Why?
| Mice, Inbred C57BL | 5 | 2016 | 1819 | 0.200 |
Why?
| N-Methylaspartate | 1 | 2022 | 27 | 0.200 |
Why?
| Caenorhabditis elegans | 2 | 2024 | 138 | 0.200 |
Why?
| Lysosomes | 2 | 2024 | 84 | 0.200 |
Why?
| Metformin | 1 | 2022 | 65 | 0.200 |
Why?
| Cell Adhesion Molecules, Neuronal | 2 | 2023 | 9 | 0.200 |
Why?
| Oxygen | 1 | 2004 | 325 | 0.200 |
Why?
| Glucose | 1 | 2023 | 338 | 0.190 |
Why?
| Autophagy | 2 | 2024 | 169 | 0.180 |
Why?
| Analysis of Variance | 3 | 2013 | 564 | 0.180 |
Why?
| Fluorescent Antibody Technique | 3 | 2011 | 113 | 0.180 |
Why?
| Ubiquitination | 1 | 2019 | 43 | 0.170 |
Why?
| Risk | 1 | 2020 | 324 | 0.170 |
Why?
| DNA-Binding Proteins | 1 | 2002 | 428 | 0.170 |
Why?
| Nitrites | 2 | 2012 | 31 | 0.170 |
Why?
| Models, Biological | 3 | 2007 | 723 | 0.170 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2019 | 95 | 0.160 |
Why?
| Insulysin | 1 | 2018 | 1 | 0.160 |
Why?
| Animals, Genetically Modified | 1 | 2018 | 49 | 0.160 |
Why?
| Proteomics | 2 | 2018 | 330 | 0.160 |
Why?
| Carbon | 1 | 2018 | 54 | 0.150 |
Why?
| Nucleotide Motifs | 1 | 2017 | 24 | 0.150 |
Why?
| D-Amino-Acid Oxidase | 2 | 2008 | 2 | 0.150 |
Why?
| Carrier Proteins | 1 | 2018 | 306 | 0.140 |
Why?
| Disease Models, Animal | 4 | 2023 | 1458 | 0.140 |
Why?
| Cell Line, Transformed | 2 | 2017 | 72 | 0.140 |
Why?
| Insulin Resistance | 1 | 2018 | 262 | 0.140 |
Why?
| TNF Receptor-Associated Factor 2 | 1 | 2016 | 4 | 0.140 |
Why?
| TNF Receptor-Associated Factor 6 | 1 | 2016 | 8 | 0.140 |
Why?
| I-kappa B Kinase | 1 | 2016 | 20 | 0.140 |
Why?
| Glycoside Hydrolases | 1 | 2016 | 21 | 0.130 |
Why?
| Autoradiography | 1 | 2016 | 33 | 0.130 |
Why?
| Forecasting | 1 | 2016 | 150 | 0.130 |
Why?
| Blood-Brain Barrier | 1 | 2016 | 48 | 0.130 |
Why?
| Transfection | 2 | 2007 | 355 | 0.130 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 244 | 0.130 |
Why?
| Anthracenes | 2 | 2005 | 9 | 0.120 |
Why?
| RNA Interference | 2 | 2013 | 179 | 0.120 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 181 | 0.120 |
Why?
| Calnexin | 1 | 2014 | 4 | 0.120 |
Why?
| Calreticulin | 1 | 2014 | 10 | 0.120 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 486 | 0.120 |
Why?
| Luciferases | 2 | 2023 | 50 | 0.120 |
Why?
| Cell Nucleus | 2 | 2006 | 187 | 0.110 |
Why?
| Cell Death | 3 | 2016 | 182 | 0.110 |
Why?
| Social Behavior Disorders | 1 | 2013 | 6 | 0.110 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2013 | 30 | 0.110 |
Why?
| Proteasome Inhibitors | 1 | 2014 | 104 | 0.110 |
Why?
| Superoxides | 1 | 2013 | 46 | 0.110 |
Why?
| Neocortex | 2 | 2014 | 8 | 0.110 |
Why?
| Neural Stem Cells | 1 | 2013 | 26 | 0.110 |
Why?
| Phosphorylation | 4 | 2018 | 534 | 0.110 |
Why?
| Muscle, Skeletal | 1 | 2018 | 765 | 0.110 |
Why?
| 1-Methyl-3-isobutylxanthine | 1 | 2012 | 8 | 0.110 |
Why?
| Liver | 1 | 2018 | 1116 | 0.110 |
Why?
| Excitatory Amino Acid Agents | 1 | 2012 | 3 | 0.110 |
Why?
| Dioxolanes | 1 | 2012 | 12 | 0.100 |
Why?
| Pentaerythritol Tetranitrate | 1 | 2012 | 1 | 0.100 |
Why?
| 3-Mercaptopropionic Acid | 1 | 2012 | 1 | 0.100 |
Why?
| Spermine | 1 | 2012 | 3 | 0.100 |
Why?
| Hypoxanthine | 1 | 2012 | 4 | 0.100 |
Why?
| Pentetic Acid | 1 | 2012 | 6 | 0.100 |
Why?
| Sodium Dodecyl Sulfate | 1 | 2012 | 3 | 0.100 |
Why?
| Nitric Oxide Donors | 1 | 2012 | 10 | 0.100 |
Why?
| Hydroxyl Radical | 1 | 2012 | 6 | 0.100 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 51 | 0.100 |
Why?
| Purines | 1 | 2012 | 38 | 0.100 |
Why?
| Peroxynitrous Acid | 1 | 2012 | 32 | 0.100 |
Why?
| Chelating Agents | 1 | 2012 | 27 | 0.100 |
Why?
| Angiotensin II | 1 | 2013 | 157 | 0.100 |
Why?
| Oxidants | 1 | 2012 | 53 | 0.100 |
Why?
| Protein Structure, Quaternary | 1 | 2011 | 26 | 0.100 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2012 | 40 | 0.100 |
Why?
| Protein Multimerization | 1 | 2011 | 48 | 0.100 |
Why?
| Hydrogen Peroxide | 1 | 2012 | 115 | 0.100 |
Why?
| Retina | 1 | 2011 | 65 | 0.090 |
Why?
| Diabetic Retinopathy | 1 | 2011 | 40 | 0.090 |
Why?
| Cell Line | 3 | 2018 | 1021 | 0.090 |
Why?
| Pregnancy | 1 | 2018 | 2604 | 0.090 |
Why?
| Mass Spectrometry | 1 | 2012 | 301 | 0.090 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2011 | 128 | 0.090 |
Why?
| Kinetics | 1 | 2011 | 631 | 0.090 |
Why?
| Recombinant Proteins | 1 | 2011 | 487 | 0.090 |
Why?
| DNA | 2 | 2004 | 541 | 0.090 |
Why?
| Amino Acids | 1 | 2012 | 362 | 0.090 |
Why?
| Neurogenic Inflammation | 1 | 2009 | 4 | 0.080 |
Why?
| I-kappa B Proteins | 1 | 2009 | 16 | 0.080 |
Why?
| Prosencephalon | 1 | 2009 | 12 | 0.080 |
Why?
| Neurogenesis | 1 | 2009 | 27 | 0.080 |
Why?
| Reversal Learning | 1 | 2008 | 5 | 0.080 |
Why?
| Cell Proliferation | 1 | 2013 | 1013 | 0.080 |
Why?
| Disease Susceptibility | 1 | 2009 | 89 | 0.080 |
Why?
| Endoplasmic Reticulum Stress | 2 | 2022 | 43 | 0.080 |
Why?
| Extinction, Psychological | 1 | 2008 | 34 | 0.080 |
Why?
| Time Factors | 2 | 2005 | 2922 | 0.080 |
Why?
| Nitriles | 2 | 2005 | 54 | 0.070 |
Why?
| Models, Molecular | 2 | 2019 | 341 | 0.070 |
Why?
| Schizophrenia | 1 | 2009 | 256 | 0.070 |
Why?
| Acetophenones | 1 | 2007 | 11 | 0.070 |
Why?
| Onium Compounds | 1 | 2007 | 13 | 0.070 |
Why?
| Butadienes | 2 | 2005 | 48 | 0.070 |
Why?
| Sp Transcription Factors | 1 | 2006 | 6 | 0.070 |
Why?
| HIV | 1 | 2006 | 24 | 0.070 |
Why?
| Ischemic Attack, Transient | 1 | 2007 | 56 | 0.070 |
Why?
| Vitamin E | 1 | 2007 | 79 | 0.070 |
Why?
| Reperfusion Injury | 1 | 2007 | 87 | 0.070 |
Why?
| Immunoglobulins | 1 | 2006 | 79 | 0.070 |
Why?
| alpha-Synuclein | 1 | 2006 | 10 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2007 | 327 | 0.070 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2003 | 155 | 0.060 |
Why?
| 2-Amino-5-phosphonovalerate | 1 | 2005 | 6 | 0.060 |
Why?
| Tetrazolium Salts | 1 | 2005 | 14 | 0.060 |
Why?
| Culture Media, Conditioned | 1 | 2005 | 48 | 0.060 |
Why?
| Nerve Degeneration | 1 | 2005 | 24 | 0.060 |
Why?
| Bone Marrow Cells | 1 | 2006 | 190 | 0.060 |
Why?
| Antioxidants | 1 | 2007 | 241 | 0.060 |
Why?
| Age Factors | 1 | 2008 | 1092 | 0.060 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2005 | 51 | 0.060 |
Why?
| Thiazoles | 1 | 2005 | 53 | 0.060 |
Why?
| Respiratory Burst | 1 | 2004 | 5 | 0.060 |
Why?
| Glutamates | 1 | 2004 | 22 | 0.060 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 67 | 0.060 |
Why?
| Mutagenesis | 1 | 2004 | 60 | 0.060 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 83 | 0.060 |
Why?
| Stem Cells | 1 | 2006 | 171 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 186 | 0.060 |
Why?
| Drug Combinations | 1 | 2005 | 126 | 0.060 |
Why?
| Sciatic Nerve | 1 | 2004 | 24 | 0.060 |
Why?
| Receptors, Lipoprotein | 1 | 2004 | 7 | 0.060 |
Why?
| Memory | 1 | 2005 | 117 | 0.060 |
Why?
| Adaptation, Physiological | 1 | 2004 | 91 | 0.060 |
Why?
| Receptors, Immunologic | 1 | 2004 | 37 | 0.060 |
Why?
| Imidazoles | 1 | 2005 | 128 | 0.060 |
Why?
| Pyridines | 1 | 2005 | 131 | 0.060 |
Why?
| Anti-Inflammatory Agents | 1 | 2004 | 160 | 0.060 |
Why?
| Synaptophysin | 1 | 2003 | 7 | 0.060 |
Why?
| Case-Control Studies | 3 | 2016 | 1126 | 0.060 |
Why?
| Receptors, LDL | 1 | 2023 | 66 | 0.050 |
Why?
| Learning | 1 | 2005 | 159 | 0.050 |
Why?
| Palmitates | 1 | 2022 | 29 | 0.050 |
Why?
| Calcium | 1 | 2005 | 400 | 0.050 |
Why?
| Cell Fractionation | 1 | 2002 | 18 | 0.050 |
Why?
| Mice, Knockout | 2 | 2018 | 846 | 0.050 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2002 | 7 | 0.050 |
Why?
| Hypothalamus | 1 | 2022 | 45 | 0.050 |
Why?
| Lipoprotein Lipase | 1 | 2002 | 12 | 0.050 |
Why?
| HEK293 Cells | 1 | 2023 | 224 | 0.050 |
Why?
| Genes, Reporter | 1 | 2002 | 88 | 0.050 |
Why?
| Fibroblasts | 1 | 2004 | 351 | 0.050 |
Why?
| Dexamethasone | 1 | 2004 | 430 | 0.050 |
Why?
| Protein Kinase C | 1 | 2002 | 71 | 0.050 |
Why?
| Oligonucleotides | 1 | 2002 | 81 | 0.050 |
Why?
| Disease Progression | 2 | 2017 | 831 | 0.050 |
Why?
| Isoenzymes | 1 | 2002 | 169 | 0.050 |
Why?
| Adipocytes | 1 | 2002 | 121 | 0.050 |
Why?
| Aged | 2 | 2019 | 9405 | 0.050 |
Why?
| Aged, 80 and over | 1 | 2008 | 3154 | 0.050 |
Why?
| Ubiquitin | 1 | 2019 | 45 | 0.040 |
Why?
| Oxidative Stress | 1 | 2004 | 771 | 0.040 |
Why?
| Mitochondria | 1 | 2022 | 404 | 0.040 |
Why?
| Enzyme Activation | 1 | 2019 | 275 | 0.040 |
Why?
| Protein Transport | 1 | 2019 | 183 | 0.040 |
Why?
| Synaptosomes | 1 | 2018 | 15 | 0.040 |
Why?
| Glucose Intolerance | 1 | 2018 | 27 | 0.040 |
Why?
| Receptor, Insulin | 1 | 2018 | 41 | 0.040 |
Why?
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 14 | 0.040 |
Why?
| Epistasis, Genetic | 1 | 2017 | 29 | 0.040 |
Why?
| Molecular Docking Simulation | 1 | 2017 | 75 | 0.040 |
Why?
| Cell Differentiation | 2 | 2013 | 650 | 0.040 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| Detergents | 1 | 2016 | 17 | 0.030 |
Why?
| Computer Simulation | 1 | 2017 | 280 | 0.030 |
Why?
| 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| Solubility | 1 | 2016 | 71 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 106 | 0.030 |
Why?
| Risk Factors | 1 | 2004 | 3629 | 0.030 |
Why?
| Oxidopamine | 1 | 2014 | 4 | 0.030 |
Why?
| Brefeldin A | 1 | 2014 | 19 | 0.030 |
Why?
| Antibodies | 2 | 2006 | 154 | 0.030 |
Why?
| Protein Disulfide-Isomerases | 1 | 2014 | 14 | 0.030 |
Why?
| Adrenergic Agents | 1 | 2014 | 15 | 0.030 |
Why?
| Receptor, Notch1 | 1 | 2013 | 4 | 0.030 |
Why?
| Cytokine Receptor gp130 | 1 | 2013 | 12 | 0.030 |
Why?
| Exploratory Behavior | 1 | 2013 | 23 | 0.030 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 118 | 0.030 |
Why?
| Middle Aged | 1 | 2008 | 12206 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2013 | 89 | 0.030 |
Why?
| Cell Count | 1 | 2013 | 149 | 0.030 |
Why?
| Psychomotor Agitation | 1 | 2013 | 51 | 0.030 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 105 | 0.030 |
Why?
| Interpersonal Relations | 1 | 2013 | 105 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2013 | 157 | 0.030 |
Why?
| Adult | 1 | 2008 | 13324 | 0.030 |
Why?
| Parkinson Disease | 1 | 2014 | 151 | 0.030 |
Why?
| Interleukin-6 | 1 | 2013 | 265 | 0.020 |
Why?
| Autistic Disorder | 1 | 2013 | 120 | 0.020 |
Why?
| Streptozocin | 1 | 2011 | 23 | 0.020 |
Why?
| Aqueous Humor | 1 | 2011 | 10 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2015 | 1416 | 0.020 |
Why?
| Random Allocation | 1 | 2011 | 282 | 0.020 |
Why?
| Up-Regulation | 1 | 2012 | 453 | 0.020 |
Why?
| Body Weight | 1 | 2011 | 512 | 0.020 |
Why?
| Pedigree | 1 | 2009 | 125 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2009 | 161 | 0.020 |
Why?
| Maze Learning | 1 | 2008 | 32 | 0.020 |
Why?
| Child, Preschool | 1 | 2013 | 3883 | 0.020 |
Why?
| Peripheral Nervous System | 1 | 2004 | 15 | 0.020 |
Why?
| Phagocytes | 1 | 2004 | 12 | 0.010 |
Why?
| Scavenger Receptors, Class B | 1 | 2004 | 10 | 0.010 |
Why?
| Blotting, Northern | 1 | 2004 | 109 | 0.010 |
Why?
| Receptors, Scavenger | 1 | 2004 | 29 | 0.010 |
Why?
| In Situ Nick-End Labeling | 1 | 2004 | 57 | 0.010 |
Why?
| Polysaccharides | 1 | 2004 | 51 | 0.010 |
Why?
| Biological Transport | 1 | 2004 | 172 | 0.010 |
Why?
| Sialoglycoproteins | 1 | 2003 | 12 | 0.010 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2003 | 15 | 0.010 |
Why?
| Interferon-gamma | 1 | 2004 | 176 | 0.010 |
Why?
| Phenotype | 1 | 2006 | 733 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2006 | 978 | 0.010 |
Why?
| Polyribosomes | 1 | 2002 | 7 | 0.010 |
Why?
| Coculture Techniques | 1 | 2003 | 146 | 0.010 |
Why?
| Protein Kinase C-alpha | 1 | 2002 | 10 | 0.010 |
Why?
| Cell Communication | 1 | 2003 | 69 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2002 | 46 | 0.010 |
Why?
| Oligonucleotides, Antisense | 1 | 2002 | 28 | 0.010 |
Why?
| MAP Kinase Signaling System | 1 | 2002 | 118 | 0.010 |
Why?
| Flow Cytometry | 1 | 2004 | 476 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2003 | 388 | 0.010 |
Why?
| Child | 1 | 2013 | 6851 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2002 | 254 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2004 | 1186 | 0.010 |
Why?
|
|
Barger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|